{"database": "lobbying", "table": "lobbying_activities", "rows": [[1738267, "9373b789-58e9-4e51-af0d-7973386e7b3d", "Q3", "WALTER CONSULTING", 301697, "AMERISOURCEBERGEN CORPORATION", 2015, "third_quarter", "PHA", "H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015\nS.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2015-10-19T12:18:48.027000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1738267"], "units": {}, "query_ms": 27.82873500837013, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}